Tim Van Hauwermeiren, argenx CEO

Ar­genx touts first-in-class win for a rare dis­ease that caus­es life-threat­en­ing mus­cle weak­ness

If you look on ar­genx’s web­site to­day, you’ll see a burst of con­fet­ti. That’s be­cause — in ad­di­tion to get­ting a new type of ther­a­py past …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.